C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01)
Patent
CA 2737667
The invention relates to targeted binding agents against CD105 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to CD105. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of CD105 and as diagnostics.
L'invention concerne des agents de liaison ciblés contre CD105 et l'utilisation de tels agents. De manière plus spécifique, l'invention concerne des anticorps monoclonaux totalement humains dirigés contre CD105. Les agents de liaison ciblés décrits sont utiles dans le traitement de maladies associées à l'activité et/ou la surproduction de CD105 et en tant qu'agents de diagnostic.
Babcook John
Barry Simon Thomas
Gazit-Bornstein Gadi
Laing Naomi
Zhou Qing
Medimmune Llc
Smart & Biggar
LandOfFree
Targeted binding agents directed to cd105 and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted binding agents directed to cd105 and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted binding agents directed to cd105 and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1899199